BVU_BEOVU_OPHTHALMOLOGY
Drug
Novartis Pharma AG
Total Payments
$37,813
Transactions
4
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $37,813 | 4 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,813 | 4 | 100.0% |
Top Doctors Receiving Payments for BVU_BEOVU_OPHTHALMOLOGY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Jeffrey Heier | Ophthalmology | Boston, MA | $15,588 | 2 |
| , MD, PHD | Retina Specialist | Houston, TX | $15,050 | 1 |
| , MD | Ophthalmology | Portland, OR | $7,175 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $37,813
Product Information
- Type Drug
- Total Payments $37,813
- Total Doctors 3
- Transactions 4
About BVU_BEOVU_OPHTHALMOLOGY
BVU_BEOVU_OPHTHALMOLOGY is a drug associated with $37,813 in payments to 3 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2020 to 2020. In 2020, $37,813 was paid across 4 transactions to 3 doctors.
The most common payment nature for BVU_BEOVU_OPHTHALMOLOGY is "Consulting Fee" ($37,813, 100.0% of total).